loading page

Mild COVID-19 manifestation in multiple risk factor patient on methotrexate, who had been treated with UVB phototherapy and had sufficient plasma 25-OH-vitamin D3 level
  • Martina Kralj,
  • Hrvoje Jakovac
Martina Kralj
General Hospital Karlovac
Author Profile
Hrvoje Jakovac
University of Rijeka Faculty of Medicine
Author Profile

Abstract

We report mild COVID-19 manifestation in high-risk patient with sufficient plasma 25-OH-Vitamin D3 level. Given the global pandemic of vitamin D deficiency, as well as its likely beneficial effects during SARS-CoV-2 infection, report highlights importance of routine 25-OH-Vitamin D3 measurement, either for clinical course prediction or deciding on supplementation.

Peer review status:ACCEPTED

17 Jan 2021Submitted to Clinical Case Reports
20 Jan 2021Submission Checks Completed
20 Jan 2021Assigned to Editor
31 Jan 2021Reviewer(s) Assigned
04 Feb 2021Review(s) Completed, Editorial Evaluation Pending
11 Feb 2021Editorial Decision: Revise Minor
14 Feb 20211st Revision Received
15 Feb 2021Submission Checks Completed
15 Feb 2021Assigned to Editor
15 Feb 2021Review(s) Completed, Editorial Evaluation Pending
16 Feb 2021Reviewer(s) Assigned
22 Feb 2021Editorial Decision: Accept